CHARLES RIVER LABORATORIES

Charles River Laboratories stock rises 1.68% to $345.37 as its 17.3% 30‑day gain highlights growing biotech research demand – see key metrics, related stocks, and upcoming SoFi earnings.

Explore Charles River Laboratories’ October 23, 2026 trading update, key market metrics, and peer comparisons—gain insights into its 22% monthly rise and industry trends.

Charles River Laboratories (CRL) climbs 9.33% as investors spot strong liquidity and a 20.96% year‑to‑date rise, backed by robust 200‑day SMA.

Charles River Laboratories stock up 5.14%—now $344.87—amid a 13% monthly rise, 52‑week high at $333.30, fueling biotech research growth.